![Todd Wider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Wider
Directeur/Bestuurslid bij
ASP ISOTOPES INC.
Vermogen: 3 M $ op 31-08-2026
Profiel
Todd Wider is currently Director at Varian Biopharmaceuticals, Inc., Director at Varian Biopharma, Inc., Independent Non-Executive Director at ASP Isotopes, Inc. since 2021, Independent Director at Genenta Science SpA since 2024, and Principal at Wider Film Projects.
Former roles include Executive Chairman & Chief Medical Officer at Emendo Biotherapeutics, Inc. from 2018 to 2024, Independent Director at Abeona Therapeutics, Inc., Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2020, Independent Director at ARYA Sciences Acquisition Corp.
II in 2020, Independent Director at ARYA Sciences Acquisition Corp.
IV, Independent Director at ARYA Sciences Acquisition Corp.
V, Independent Director at ARYA Sciences Acquisition Corp.
III from 2020 to 2021, Director at Lyfebulb LLC, and Principal at Memorial Sloan Kettering Cancer Center.
Education includes undergraduate studies at Princeton University and a doctorate from Columbia University College of Physicians & Surgeons.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASP ISOTOPES, INC. 0,44% | 30-06-2026 | 672.247 ( 0,44% ) | 3 M $ | 31-08-2026 |
Actieve functies van Todd Wider
| Bedrijven | Functie | Begin |
|---|---|---|
| ASP ISOTOPES INC. | Directeur/Bestuurslid | 01-10-2021 |
Wider Film Projects | Corporate Officer/Principal | - |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Directeur/Bestuurslid | - |
Eerdere bekende functies van Todd Wider
| Bedrijven | Functie | Einde |
|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Voorzitter | 01-03-2024 |
| ARYA SCIENCES ACQUISITION III A | Directeur/Bestuurslid | 01-06-2021 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Directeur/Bestuurslid | 01-11-2020 |
| ARYA SCIENCES ACQUISITION CORP. | Directeur/Bestuurslid | 01-03-2020 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
Opleiding van Todd Wider
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Lyfebulb LLC
 Lyfebulb LLC Internet Software/ServicesTechnology Services Operates as an online digital platform for people living with chronic illnesses | Technology Services |
Wider Film Projects | |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
